Harmony Biosciences Holdings (HRMY) Tax Rate (2021 - 2026)
Harmony Biosciences Holdings (HRMY) posted Tax Rate of 18.14% for Q1 2026, up 130.18% sequentially from 60.11% in Q4 2025, and down 218.0% YoY from 15.37% in Q1 2025.
Harmony Biosciences Holdings (HRMY) Tax Rate (2021 - 2026) Analysis & Trends
Harmony Biosciences Holdings has reported Tax Rate for 6 years, with the latest figure at 18.14% in Q1 2026.
- Quarterly Tax Rate fell 218.0% year-over-year to 18.14% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 4.65% (down 1791.0% YoY) and the FY2025 annual result came in at 6.32%, down 1782.0% from the prior year.
- Tax Rate improved to 18.14% in Q1 2026 per HRMY's latest filing, from 60.11% in the prior quarter.
- Over five years, Tax Rate peaked at 46.57% in Q2 2024 and troughed at 1003.84% in Q3 2022.
- A 5-year average of 44.13% and a median of 20.32% in 2025 frame the typical range for Tax Rate.
- The sharpest annual moves came in 2022 and 2023: Tax Rate tumbled 101241 bps in 2022, then surged 102964 bps in 2023.
- Over 5 years, Tax Rate stood at 9.99% in 2022, then jumped by 430 bps to 32.96% in 2023, then slumped by 64 bps to 11.9% in 2024, then slumped by 605 bps to 60.11% in 2025, then jumped by 130 bps to 18.14% in 2026.
- According to Business Quant data, Tax Rate over the past three periods registered 18.14%, 60.11%, and 24.63% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.91% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 24.15% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -9.47% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 7.49% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.71% |
| 10 | Harmony Biosciences Holdings | 2.22 Bn | 1.41 Bn | 198.08 Mn | 21.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.00% |
| Jun 30, 2026 | 21.00% |
| Jun 30, 2026 | 21.00% |
| Mar 31, 2026 | 18.14% |
| Mar 31, 2026 | 18.14% |
| Mar 31, 2026 | 18.14% |
| Dec 31, 2025 | -60.11% |
| Dec 31, 2025 | -60.11% |
| Dec 31, 2025 | -60.11% |
| Sep 30, 2025 | 24.63% |
| Sep 30, 2025 | 24.63% |
| Sep 30, 2025 | 24.63% |
| Jun 30, 2025 | 19.87% |
| Jun 30, 2025 | 19.87% |
| Jun 30, 2025 | 19.87% |
| Mar 31, 2025 | 20.32% |
| Mar 31, 2025 | 20.32% |
| Mar 31, 2025 | 20.32% |
| Dec 31, 2024 | 11.90% |
| Dec 31, 2024 | 11.90% |